Display options
Share it on

Korean J Neurotrauma. 2015 Oct;11(2):147-50. doi: 10.13004/kjnt.2015.11.2.147. Epub 2015 Oct 31.

Effect of Alpha-1-Adrenergic Agonist, Midodrine for the Management of Long-Standing Neurogenic Shock in Patient with Cervical Spinal Cord Injury: A Case Report.

Korean journal of neurotrauma

Taikwan Kim, Cheol Su Jwa

Affiliations

  1. Department of Neurosurgery, National Medical Center, Seoul, Korea.

PMID: 27169082 PMCID: PMC4847524 DOI: 10.13004/kjnt.2015.11.2.147

Abstract

We report a rare case of a 71-year-old male patient who had suffered from long-lasting neurogenic shock for 13 weeks after cervical spinal cord injury (SCI) caused by a bicycle accident. The neurogenic shock was resolved dramatically 2 weeks after the administration of alpha-1-adrenergic agonist, midodrine hydrochloride. In usual cases, neurogenic shock tends to improve between 2 and 6 weeks after SCI; however, in a few cases, the shock lasts for several months. In our case, spinal shock lasted for 13 weeks and exhibited very sensitive decline of blood pressure for even a slight decrease of dopamine despite recovered bulbospongiosus reflex. Three days after midodrine hydrochloride was added, hypotension improved dramatically. We discuss our rare case with pertinent literatures.

Keywords: Adrenergic alpha-agonists; Hypotension; Midodrine; Spinal cord injuries

References

  1. J Spinal Cord Med. 2004;27(3):219-25 - PubMed
  2. Eur J Clin Pharmacol. 1979;16(6):423-4 - PubMed
  3. Neurology. 1998 Jul;51(1):120-4 - PubMed
  4. Spinal Cord. 2000 Feb;38(2):109-11 - PubMed
  5. Drugs. 1989 Nov;38(5):757-77 - PubMed
  6. Acta Neurol Scand Suppl. 2011;(191):71-8 - PubMed
  7. J Neurotrauma. 2011 Aug;28(8):1479-95 - PubMed
  8. N Engl J Med. 2008 Feb 7;358(6):615-24 - PubMed
  9. Arch Phys Med Rehabil. 2000 Apr;81(4):506-16 - PubMed
  10. Arch Phys Med Rehabil. 2001 May;82(5):694-6 - PubMed

Publication Types